Serum Iron and Hepcidin Levels Associated With Osteoporosis in Patients With Rheumatoid Arthritis
Researchers aimed to determine whether iron metabolism and serum hepcidin levels were linked to osteoporosis in patients with rheumatoid arthritis.
Osteoporosis
Low Physical Function, Lean Body Mass Predict Accelerated Bone Loss After Hip Fracture
Lower physical function and lean body mass are associated with increased risk for accelerated bone loss in older patients with previous hip fracture.
Abaloparatide Increases BMD in Younger Postmenopausal Women at High Risk for Fracture
Abaloparatide treatment significantly increases bone mineral density in younger postmenopausal women at high risk for fracture.
Serum Uric Acid Levels Linked to Reduced Hip Osteoporosis Risk in Postmenopausal Women With RA
Researchers assessed the association between serum uric acid levels and osteoporosis risk in postmenopausal women with rheumatoid arthritis.
Inhibition of Sclerostin With Romosozumab May Increase Cardiovascular Risk
Inhibition of sclerostin with romosozumab may increase cardiovascular risk.
Evaluating the Effects of Follow-Up Therapy After Denosumab Discontinuation in Postmenopausal Osteoporosis
Researchers evaluated the effects of follow-up therapy after denosumab discontinuation on bone resorption, bone mineral density, and clinical fracture risk.
Measuring Bone Characteristics and Derangement in Patients With Adrenal Incidentaloma
High-resolution peripheral quantitative computed tomography can be used to assess bone abnormalities in patients with adrenal incidentaloma.
Dairy Intake May Not Affect BMD During Menopausal Transition
Level of dairy intake does not affect the rate of bone mineral density loss or fracture risk among perimenopausal women.
Updated AACE/ACE Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis: What Do Clinicians Need to Know?
The ACE and AACE released a 2020 update to their clinical practice guidelines for the treatment and diagnosis of postmenopausal osteoporosis.
Low-Dose Denosumab May Be Effective in Maintaining BMD in Postmenopausal Osteoporosis
Researchers evaluated the efficacy of low-dose denosumab for maintaining bone mineral density in postmenopausal women with osteoporosis.
-
Loading...
-
Loading...
Next post in Osteoporosis
